Nuclear topography of the 1q21 genomic region and Mcl-1 protein levels associated with pathophysiology of multiple myeloma

Neoplasma

Volumn 56, Issue 5, 2009, Pages 404-413

  Legartova, S ^a   Krejci, J ^a   Harnicarova, A ^a   Hajek, R ^b   Kozubek, S ^a   Bartova, E ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

1q21; DNA FISH; Multiple myeloma

Indexed keywords

CYCLIN D1; DEXAMETHASONE; IMMUNOGLOBULIN HEAVY CHAIN; MELPHALAN; MYC PROTEIN; PROTEIN MCL 1; PROTEIN P53; SYNDECAN 1; CCND1 PROTEIN, HUMAN; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTEIN BCL 2; TUMOR MARKER;

ARTICLE; BONE MARROW; CHROMOSOMAL INSTABILITY; CHROMOSOME 1Q; CHROMOSOME MAP; CONTROLLED STUDY; DRUG EFFECT; GAMMA RADIATION; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; INTERPHASE; KARYOTYPE; LYMPHOBLASTOID CELL LINE; MARKER GENE; MULTIPLE MYELOMA; MYELOMA CELL; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PROGNOSIS; CELL NUCLEUS; CHROMOSOME 1; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL NUCLEUS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CYCLIN D1; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INTERPHASE; MULTIPLE MYELOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 69849112609     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_05_404     Document Type: Article

References (42)

1. PRATT G. Molecular aspects of multiple myeloma. Mol Pathol. 2002; 55: 273-283. Review. doi:10.1136/mp.55.5.273 PMid:12354927 PMCid:1187254
2. FONSECA R, BAILEY RJ, AHMANN GJ, et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood. 2002; 100: 1417-1424. (Pubitemid 34864300)
3. SMADJA NV, BASTARD C, BRIGAUDEAU C et al., Groupe Français de Cytogénétique Hématologique. Hypodiploidy is a major prognostic factor in multiple myeloma. Blood. 2001; 98: 2229-2238. doi:10.1182/blood.V98.7.2229 PMid:11568011
4. KUEHL WM, BERGSAGEL PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002; 2: 175-187. doi:10.1038/nrc746 PMid:11990854
5. CREMER FW, BILA J, BUCK I, et al. Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics. Genes Chromosomes Cancer. 2005(a); 44: 194-203.
6. SHAUGHNESSY J, TIAN E, SAWYER J, et al. High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood. 2000; 96: 1505-1511.
7. CREMER FW, KARTAL M, HOSE D, et al. High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH. Cancer Genet Cytogenet. 2005(b); 161: 116-124.
8. AVET-LOISEAU H, GERSON F, MAGRANGEAS F, et al. Intergroupe Francophone du Myelome. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood. 2001; 98: 3082-3086. doi:10.1182/blood. V98.10.3082 PMid:11698294
9. LIU P, LEONG T, QUAM L, et al. Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial. Blood. 1996; 88: 2699-2706.
10. HAROUSSEAU JL, SHAUGHNESSY J JR, RICHARDSON P. Multiple myeloma. Hematology Am Soc Hematol Educ Program. 2004; 237-256. doi:10.1182/asheducation- 2004.1.237
11. KUDOH K, KIKUCHI Y, KITA T et al. Preoperative determination of several serum tumor markers in patiens with primary epithelial ovaria carcinoma. Gynecol Obstet Invest. 1999; 47: 52-57. doi:10.1159/000010062 PMid:9852392
12. TARKKANEN M, HUUHTANEN R, VIROLAINEN M. et al. Comparison of genetic changes in primary sarcomas and their pulmonary metastases. Genes Chromosome Cancer. 1999; 25: 323-331 doi:10.1002/(SICI)1098-2264(199908)25:4〈323::AID- GCC3〉3.0.CO;2-5 PMid:10398425
13. PETERSEN I, HIDALGO A, PETERSEN S, et al. Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol. 2000; 10: 395-401. (Pubitemid 30431292)
14. ITOYAMA T, NANJUGUD G, CHEN W, et al. Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodkin lymphoma. Genes Chromosomes Cancer. 2002; 35: 318-328 doi:10.1002/gcc.10120 PMid:12378526
15. HANAMURA I, STEWART JP, HUANG Y, et al. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood. 2006; 108: 1724-1732. doi:10.1182/blood-2006-03-009910 PMid:16705089 PMCid:1895503
16. SONNEVELD P. Gain of 1q21 in multiple myeloma from bad to worse. Blood. 2006; 108: 1426-1427. doi:10.1182/blood-2006-06-028530
17. WALKER, BA, LEONE, PE, JENNER, MW, et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood 2006; 108: 1733-1734. doi:10.1182/blood-2006-02-005496 PMid:16705090
18. SHAUGHNESSY J. Amplification and overexpression of CDK1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma. Hematology. 2005; 10: 117-126. doi:10.1080/10245330512331390140 PMid:16188652
19. DREWINKO B, MARS W, MINOWADA J, et al. ARH-77, an established human IgG-producing myeloma cell line. I. Morphology, B-cell phenotypic marker profile, and expression of Epstein-Barr virus. Cancer. 1984(a); 54: 1883-1892.
20. DREWINKO B, MARS W, STRAGAND JJ, et al. ARH-77, an established human IgG-producing myeloma cell line. II. Growth kinetics, clonogenic capacity, chalone production, xenogeneic transplantations, and response to melphalan. Cancer. 1984(b); 54: 1893-1903.
21. BAE J, LEO CP, HSU SY, et al. MCL-1S, a Splicing variant of the antiapoptic Bcl-2 member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem. 2000; 275: 25255-25261. doi:10.1074/jbc.M909826199 PMid:10837489 (Pubitemid 30687021)
22. LE GOUILL S, PODAR K, HAROUSSEAU JL et al. Mcl-1 regulation and ist role in multiple myeloma. Cell Cycle. 2004; 3: e107-e110.
23. FIŠEROVÁ A, HÁJEK R, HOLUBOVÁ V, et al. Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells. Neoplasma. 2002; 49: 300-306.
24. BÁRTOVÁ E, KOZUBEK S, JIRSOVÁ P, et al. Higher- order chromatin structure of human granulocytes. Chromosoma. 2001;110: 360-370. doi:10.1007/s004120100141 PMid:11685536 (Pubitemid 32926902)
25. BÁRTOVÁ E, KOZUBEK S, KOZUBEK M, et al. The influence of the cell cycle, differentiation and irradiation on the nuclear location of the abl, bcr and c-myc genes in human leukemic cells. Leuk Res. 2000; 24: 233-241. doi:10.1016/S0145-2126(99)00174-5 PMid:10739005
26. BÁRTOVÁ E, KOZUBEK S, GAJOVÁ H et al. Cytogenetics and cytology of retinoblastomas. J Cancer Res Clin Oncol. 2003; 129: 89-99.
27. TASLEROVÁ R, KOZUBEK S, LUKÁŠOVÁ E et al. Arrangement of chromosome 11 and 22 territories, EWSR1 and FLI1 genes, and other genetic elements of these chromosomes in human lymphocytes and Ewing sarcoma cells. Hum Genet. 2003; 112: 143-155.
28. TASLEROVÁ R, KOZUBEK S, BÁRTOVÁ E et al. Localization of genetic elements of intact and derivative chromosome 11 and 22 territories in nuclei of Ewing sarcoma cells. J Struct Biol. 2006; 155: 493-504. doi:10.1016/j.jsb.2006.05.005 PMid:16837212
29. KREJ̌Í J, HARNIČAROVÁ A, KŮROVÁ J et al. Nuclear organization of PML bodies in leukaemic and multiple myeloma cells. Leuk Res. 2008; 32: 1866-1877. doi:10.1016/j.leukres.2008.04.021 PMid:18534676
30. HARNIČAROVÁ A, KOZUBEK S, PACHERNÍK J et al. Distinct nuclear arrangement of active and inactive c-myc genes in control and differentiated colon carcinoma cells. Exp Cell Res. 2006; 312: 4019-4035. doi:10.1016/j.yexcr.2006.09.007 PMid:17046748
31. KOZUBEK M, KOZUBEK S, LUKÁŠOVÁ E, et al. High-resolution cytometry of FISH dots in interphase cell nuclei. Cytometry.1999; 36: 279-293. doi:10.1002/(SICI)1097-0320(19990801)36:4〈279: :AID-CYTO2〉3.0.CO;2-G PMid:10404143
32. BÁRTOVÁ E, HARNIČAROVÁ A, PACHERNÍK J, et al. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference. Leuk Res. 2005; 29: 901-913. doi:10.1016/j.leukres.2005.01.011 PMid:15978941
33. MATSUO Y, DREXLER HG, HARASHIMA A, et al. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin. Leuk Res. 2004; 28: 869-877. doi:10.1016/j.leukres.2003.12.008 PMid:15203285
34. JIRSOVÁ P, KOZUBEK S, BÁRTOVÁ E, et al. Spatial distribution of selected genetic loci in nuclei of human leukemia cells after irradiation. Radiat Res. 2001; 155: 311-319. doi:10.1667/0033-7587(2001) 155[0311:SDOSGL]2.0.CO;2PMid:11175666
35. PRUNERI G, FABRIS S, BALDINI L, et al. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). Am J Pathol. 2000; 156: 1505-1513.
36. WILLIAMS RR, AZUARA V, PERRY P, et al. Neural induction promotes large-scale chromatin reorganisation of the Mash1 locus. J Cell Sci. 2006; 119: 132-140. doi:10.1242/jcs.02727 PMid:16371653
37. ZINK D, AMARAL MD, ENGLMANN A, et al. Transcription-dependent spatial arrangements of CFTR and adjacent genes in human cell nuclei. J Cell Biol. 2004; 166: 815-825. doi:10.1083/jcb.200404107 PMid:15364959 PMCid:2172106
38. BÁRTOVÁ E, KOZUBEK S. Nuclear architecture in the light of gene expression and cell differentiation studies. Biol Cell 2006; 98: 323-336. doi:10.1042/BC20050099 PMid:16704376 (Pubitemid 43853420)
39. KOZUBEK S, LUKÁŠOVÁ E, RÝZNAR L, et al. Distribution of ABL and BCR genes in cell nuclei of normal and irradiated lymphocytes. Blood. 1997; 89: 4537-4545.
40. ROIX JJ, MCQUEEN PG, MUNSON PJ et al. Spacial proximity of translocation-prone gene loci in human lymphomas. Nat Genet. 2003; 34: 287-291. doi:10.1038/ng1177 PMid:12808455
41. SOUTOGLOU E, MISTELI T. Mobility and immobility of chromatin in transcription and genome stability. Curr Opin Genet Dev. 2007; 17: 435-42. Epub 2007 Oct 1. Review. doi:10.1016/j.gde.2007.08.004 PMCid:2118061
42. MEABURN KJ, MISTELI T. Locus-specific and activity-independent gene repositioning during early tumorigenesis. J Cell Biol. 2008; 180: 39-50. doi:10.1083/jcb.200708204 PMid:18195100 PMCid:2213600